The boundary between medicinal products and medical devices remains a recurring issue for companies developing or marketing borderline products and courts, which has already been the subject of numerous decisions. Recently,...more
4/1/2025
/ Appeals ,
Court of Justice of the European Union (CJEU) ,
EU ,
Judicial Authority ,
Life Sciences ,
Manufacturers ,
Medical Devices ,
New Regulations ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Regulatory Requirements